| |
 |
|
|
|
|
|
Poster: 95
Visits: 29
Title: FVIIa-CTP, a novel long acting FVIIa, Comprehensive Pharmacokinetics and Pharmacodynamics and Bioavailability evaluation following Subcutaneous (SC) and Intravenous (IV) administration to hemophilic animal models.
Authors: Gili Hart ,
Centre: OPKO Biologics
|
|
You must be registered to reply or comment.
|
|
FVIIA-CTP, A NOVEL LONG ACTING FVIIA, COMPREHENSIVE PHARMACOKINETICS AND PHARMACODYNAMICS AND BIOAVAILABILITY EVALUATION FOLLOWING SUBCUTANEOUS (SC) AND INTRAVENOUS (IV) ADMINISTRATION TO HEMOPHILIC ANIMAL MODELS.
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 98
Visits: 72
Title: Factor VIIa-CTP , a novel FVIIa potentially supporting subcutaneous treatment - comprehensive assessment in Hemophilic animals models in preparation for first in human study.
Authors: Gili Hart ,
Centre: OPKO Biologics
|
|
|
|
